Associate Professor Beverley Lawton
University of Otago
He Tapu Te Whare Tangata
36 months

Lay summary

Māori women are more than twice as likely to be diagnosed with cervical cancer and three times more likely to die of cervical cancer than Pākehā women. The Human Papilloma Virus (HPV) is the cause of cervical cancer. HPV testing is new technology which will replace present cervical cytology screening in the future. Prevention and early detection remain the key interventions for addressing Māori needs and reducing inequalities in cervical cancer in New Zealand. To meet this need we have designed a community based Kaupapa Māori research project called He Tapu Te Whare Tangata to improve access to cervical cancer screening. He Tapu Te Whare Tangata gives Māori ownership of the process of instigating this innovative HPV screening using a community research partnership model rather than responding to future national models that may not suit Māori needs. To improve health outcomes for Māori its essential to have input and collaboration.

Back to Funding Recipients